What we know

What we know

What we know

The SMC team produces explanatory articles on topical issues to answer society’s questions, with the necessary context and depth.

Questions and answers on the Marburg virus outbreak in Rwanda

In Rwanda, according to the latest ECDC data, 25 cases and 11 deaths have been detected in what is already the third largest outbreak of the Marburg virus to date. The WHO considers the overall risk to be low and possible imported cases from Belgium and Germany - reported only yesterday in Hamburg - have proved to be false alarms. What is of concern is the national and regional spread of a virus for which mortality can be as high as 88% and for which there is no treatment or vaccine. In this article we answer the main questions.

0

Questions and Answers about CAR-T Cell Treatments and the Risk of Secondary Tumors

The regulatory agencies for medicines in the United States and Europe have issued statements informing about a possible risk of developing certain types of tumors following CAR-T cell immunotherapy treatment. What do we know so far? What is the real risk? Does the benefit-risk balance still hold? Has anything changed after these alerts? We answer these questions with expert opinions and the data currently available. 

0

Mosquito-borne diseases: an increasing risk in Spain

International health organisations are warning about the spread in Europe of mosquito species that transmit diseases such as dengue fever. In Spain, where they are already widespread across much of the country, the Centro de Coordinación de Alertas y Emergencias Sanitarias (CCAES) warns of the risk of West Nile virus, and says that the summer is expected to be complicated. In this guide, we bring together information to understand this public health issue. 

0

Ticks, transmitters of diseases now included in health surveillance plan

The third part of the National Plan for Surveillance and Control of Vector-borne Diseases is presented today, focusing on ticks, parasitic mites that cause serious diseases. Of these, the two of greatest concern in Spain are Lyme disease and Crimean-Congo haemorrhagic fever. Cases are expected to increase, but so far there has been no surveillance. International health authorities have also warned of the risks of Lyme disease in connection with the European Football Championship being held in Germany in recent weeks. 

0

Electronic cigarettes: a quick guide to the different types, their risks and whether they are useful to quit smoking

E-cigarettes, vapes, pods, mods... The popularity of these devices continues to grow, especially among young people. According to a Spanish survey, more than half of the adolescents aged 14 to 18 have used them at some point. Vaping control varies from country to country: in Spain, vaping products have been regulated since 2017 and the new anti-smoking plan aims to equate their legislation to that of tobacco, while the United States imposes fewer restrictions. In this brief guide, we explain what is known and not known on controversial issues such as the safety of electronic cigarettes, their risks or whether they are useful to quit tobacco.

 

0

What do we know about the use of medical cannabis? Questions and answers about its regulation in Spain

This week, Spain’s Ministry of Health launched a process to develop a Royal Decree on the medical use of cannabis, assuring that it will be "a rigorous measure based on the best scientific evidence available.” The goverment is conducting a public consultation until 4 March to gather the opinions of citizens, civil society organisations, professional associations and scientific societies. In this explainer, we attempt to answer the main questions that arise regarding the medical use of cannabis. 

0

What do we know about scientific misconduct? A guide to reporting about research integrity

According to a survey conducted in Spain, with 403 respondents from the biomedical research field, four out of ten admit to having committed some type of misconduct in their work. The press regularly reports on scandals in science. Among the most recent cases, El País reported that the CSIC has opened a disciplinary proceeding against five individuals suspected of receiving money in exchange of false affiliations. These cases of misconduct may seem isolated, but they reflect broader dysfunction of the research system. In this guide, we provide keys to better understand how these cases arise and evolve, and to cover their nuances. 

0